{"id":87,"date":"2026-08-31T02:14:43","date_gmt":"2026-08-31T06:14:43","guid":{"rendered":"https:\/\/pauseproof.com\/articles\/perimenopause-blood-test-normal\/"},"modified":"2026-09-20T05:05:08","modified_gmt":"2026-09-20T09:05:08","slug":"perimenopause-blood-test-normal","status":"publish","type":"post","link":"https:\/\/pauseproof.com\/articles\/perimenopause-blood-test-normal\/","title":{"rendered":"Your Hormone Test Came Back Normal. Here Is What It Can and Cannot Rule Out"},"content":{"rendered":"\n

A normal FSH result does not rule out perimenopause. The hormone swings from one cycle to the next, so an ordinary ovulatory cycle can produce a reading no different from one taken ten years earlier. What the result is worth also depends on your age, because UK guidance treats a test at 44 and a test at 46 quite differently.<\/strong><\/p>\n\n\n\n

You went in with symptoms. You came out with a printout saying your levels sit inside the reference range, and the conversation ended there. It is worth knowing what that piece of paper was actually able to answer.<\/p>\n\n\n\n

What does a normal FSH result actually mean?<\/h2>\n\n\n\n

Follicle stimulating hormone, or FSH, is the signal the pituitary gland sends to the ovaries. As ovarian follicle numbers fall, that signal tends to rise. This is why FSH became the standard menopause blood test in the first place.<\/p>\n\n\n\n

The number on your report is compared against a reference range built from a population, not from you. For a woman who is still having periods, that comparison is usually against premenopausal values. The European Menopause and Andropause Society states the practical threshold plainly in its 2022 Menopause Essentials<\/em> briefing on diagnostic tests<\/a>: menopausal women have FSH levels above 30 IU\/L.<\/p>\n\n\n\n

Notice what that threshold is for. It marks menopause, and no guideline body defines an equivalent number for perimenopause. So a result inside the range answers the question does this look postmenopausal<\/em>, which is not the question most people book the appointment to ask.<\/p>\n\n\n\n

\"Two
FSH is a pituitary signal that swings between cycles, which is why one draw captures one day.<\/figcaption><\/figure>\n\n\n\n

Why can FSH read normal when you feel anything but?<\/h2>\n\n\n\n

Because on a good cycle, it genuinely is normal. This is the part that rarely gets explained.<\/p>\n\n\n\n

A 2004 study in the Journal of Clinical Endocrinology and Metabolism<\/em><\/a> followed 13 healthy women approaching menopause, taking blood three times a week for four weeks every year, for between four and nine years before their final period. The researchers sorted the cycles into two kinds. Ordinary ovulatory cycles showed no change in hormone profile across the entire period. What shifted was the proportion of cycles that were the other kind, the prolonged ones with raised FSH, which rose to 62% of cycles in the last ten before menopause. This was a small sample of 13 women, so the proportions are not population figures.<\/p>\n\n\n\n

Put simply: for years, some of your cycles look exactly as they always did, and some do not. A blood test samples one day of one of them.<\/p>\n\n\n\n

\n

Reviewing the endocrine data in Recent Progress in Hormone Research<\/em> in 2002<\/a>, Henry Burger and colleagues concluded that the perimenopause is a time of markedly fluctuating hormone levels, and that attempts to define menopausal status purely on the basis of single measurements of FSH or oestradiol are unlikely to yield useful information.<\/p>\n<\/blockquote>\n\n\n\n

He returned to it in Menopause International<\/em> in 2011<\/a>, noting that 40% to 60% of cycles in the late transition are anovulatory, and that ovulatory cycles carry endocrine characteristics that are not specific to any one stage.<\/p>\n\n\n\n

Is my oestrogen supposed to be low?<\/h2>\n\n\n\n

Not necessarily, and this is where the popular account of perimenopause parts company with the measurements. A 2009 study in Menopause<\/em><\/a> sampled 77 women three times a week across more than a full cycle. In 11 of the 29 ovulatory cycles from women in the early and late transition, so 37% of them, oestradiol rose a second time during the luteal phase, a pattern the authors named a luteal out of phase event. Those cycles also carried higher early cycle FSH and lower luteal progesterone, and were linked to unusually short or unusually long cycles.<\/p>\n\n\n\n

So oestradiol during the transition can be high, low, or unremarkable, sometimes within the same few months. A single oestradiol figure inside the reference range tells you about that morning.<\/p>\n\n\n\n

Does my age change what the test result is worth?<\/h2>\n\n\n\n

Substantially, and this is the detail most often lost. NICE guideline NG23<\/a>, last updated on 7 November 2024, does not give one rule about hormone testing. It gives different rules by age.<\/p>\n\n\n\n

Your age<\/th>How NICE says perimenopause or menopause is identified<\/th>Where a blood test fits<\/th>Recommendation<\/th><\/tr><\/thead>
Under 40<\/td>Menopause suspected on clinical grounds<\/td>Serum FSH may be used where menopause is suspected<\/td>1.3.6<\/td><\/tr>
40 to 45<\/td>Menopause associated symptoms, including a change in the menstrual cycle<\/td>NICE says to consider serum FSH to confirm<\/td>1.3.6<\/td><\/tr>
45 and over<\/td>Recently started vasomotor symptoms plus any change in the menstrual cycle<\/td>Identify without laboratory tests<\/td>1.3.1<\/td><\/tr>
45 and over, tests NICE names as not to be used<\/td>Not applicable<\/td>Anti Mullerian hormone, inhibin A, inhibin B, oestradiol, antral follicle count, ovarian volume. FSH is not on this list in the 2024 text<\/td>1.3.4<\/td><\/tr>
Any age, using combined oestrogen and progestogen contraception or high dose progestogen<\/td>Harder to identify while on hormonal treatment<\/td>FSH is not to be used<\/td>1.3.5<\/td><\/tr><\/tbody><\/table>
Source: NICE guideline NG23, Menopause: identification and management, updated 7 November 2024.<\/figcaption><\/figure>\n\n\n\n

If you are 42 and were offered an FSH test, that was guideline consistent. Recommendation 1.3.6 says to consider one in people aged 40 to 45 with menopause associated symptoms including a cycle change. A great many articles state flatly that hormone testing is useless for perimenopause. For the 40 to 45 band, that is not what the guideline says, and if you have been told you are too young for perimenopause<\/a>, the age bands are worth reading closely.<\/p>\n\n\n\n

The sources also disagree here, and that is worth naming rather than smoothing over. The British Menopause Society tool for clinicians, published in March 2025<\/a>, states that blood tests are rarely required to diagnose perimenopause or menopause in women aged 45 or over and should not be used, adding that FSH levels fluctuate significantly and bear no correlation to the severity or duration of symptoms. The 2015 version of NG23 also carried standalone wording against serum FSH above 45. That sentence is not in the 2024 update, where the list of tests not to use above 45 does not name FSH at all. The older wording is still widely quoted in local NHS guidance and health articles, so you may meet both versions in one afternoon of searching. Guidance bodies reading the same evidence and landing in different places is not unusual in this field, and where the guidelines disagree about low mood in perimenopause<\/a> is another place it happens in the open.<\/p>\n\n\n\n

Why is every search result trying to sell me a hormone test?<\/h2>\n\n\n\n

Search this question and most of the first page is published by companies selling hormone panels, at home kits or menopause subscriptions. The pages explaining whether you need a test are largely written by the people selling it.<\/p>\n\n\n\n

There is now peer reviewed evidence on those products. A cross sectional review published in the BMJ<\/em> in 2025<\/a> examined self tests on sale in UK supermarkets, pharmacies and health shops. Researchers identified 35 tests and obtained 30 of them, covering 20 different biomarkers. Four of the thirty were menopause tests, and all four measured FSH in urine.<\/p>\n\n\n\n